By
Latest Stories
Don’t miss our hot and upcoming stories
Can AI-Powered Drug Discovery Redefine Cardiometabolic Treatment? Novo Nordisk and Valo Health Expand $4.6B Collaboration to Target Obesity, Diabetes, and Heart Disease
Key Takeaways for Industry Leaders A Landmark Expansion: 20 Programs, $4.6 Billion, and a Bold…
Recursion Advances AI-Powered Oncology Pipeline with REC-3565 and REC-4539
Salt Lake City – January 7, 2025 Recursion, a clinical-stage TechBio company pioneering the integration…
Pfizer Expands Deal to $610M, AI Drug Discovery Partnership with PostEra to Advance Small Molecules and ADCs
Boston – Jan 7, 2025 Strengthening AI-Driven Innovation in Small Molecules and ADCs Pfizer has…
Terray’s AI-Driven Drug Discovery Platform Secures Collaboration with Gilead
Boston – Dec 17, 2024 Strategic Expansion Following $120M Series B Terray Therapeutics is closing…